Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) General Information
Description
Operator of Finished Dosage Form business based in Cleveland, Ohio. The business unit develops, manufactures, packs and distributes lyophilized vials and aseptically filled ready-to-use IV bag products.
Contact Information
Corporate Office
- Cleveland, OH
- United States
Corporate Office
- Cleveland, OH
- United States
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) FAQs
-
Where is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) headquartered?
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is headquartered in Cleveland, OH.
-
What industry is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) in?
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s primary industry is Pharmaceuticals.
-
Is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) a private or public company?
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is a Private company.
-
What is the current valuation of Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)?
The current valuation of Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is .
-
What is Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s current revenue?
The current revenue for Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) is .
-
Who are Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)’s investors?
Xellia Pharmaceuticals has invested in Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets).
-
When was Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) acquired?
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) was acquired on 10-Sep-2024.
-
Who acquired Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets)?
Xellia Pharmaceuticals (US Finished Dosage Form Business and Assets) was acquired by Hikma Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process